Graham G. Walmsley is a director of Akero Therapeutics Inc.
Person profile
Roles
Akero Therapeutics
Director
Olema Pharmaceuticals
Director
Address
San Francisco, California
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Akero Therapeutics, Inc.
23 May 23
4/A
Olema Pharmaceuticals, Inc.
27 Jun 22
4
Olema Pharmaceuticals, Inc.
17 Jun 22
4
Akero Therapeutics, Inc.
3 Jun 22
4
ALX ONCOLOGY HOLDINGS INC
15 Jun 21
4
Olema Pharmaceuticals, Inc.
10 Jun 21
4
Akero Therapeutics, Inc.
3 Jun 21
4
ALX ONCOLOGY HOLDINGS INC
15 Dec 20
4
Olema Pharmaceuticals, Inc.
23 Nov 20
3
Lifesci Acquisition II Corp.
20 Nov 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 Sep 23 | AKRO Akero Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 26 | 400,000 | 10.40 mm | 400,000 |
| 19 May 23 | AKRO Akero Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 42 | 120,000 | 5.04 mm | 520,000 |
| 17 Jun 22 | OLMA Olema Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.61 | 21,520 | 77.69 k | 21,520 |
| 16 Jun 22 | OLMA Olema Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.43 | 21,520 | 73.81 k | 21,520 |
| 2 Jun 22 | AKRO Akero Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.13 | 15,000 | 121.95 k | 15,000 |